Figures & data
Figure 1. Structural transition behavior of the ELPs with respect to temperature change responsible for its ITT behavior.
![Figure 1. Structural transition behavior of the ELPs with respect to temperature change responsible for its ITT behavior.](/cms/asset/315ff477-0b91-4132-b490-0d20f45cfcd0/idrd_a_853210_f0001_b.jpg)
Figure 4. ELP-Doxorubicin conjugate. The ELP was coupled to Doxorubicin at its C-13 position through a hydrolysable hydrazone linkage.
![Figure 4. ELP-Doxorubicin conjugate. The ELP was coupled to Doxorubicin at its C-13 position through a hydrolysable hydrazone linkage.](/cms/asset/dd6edd29-6d2f-4558-b318-ec7223a8f45e/idrd_a_853210_f0004_b.jpg)
Figure 7. Cytotoxicity effect of ELP, Doxorubicin and ELP-Doxorubicin conjugate on BMG-1 cell lines.
![Figure 7. Cytotoxicity effect of ELP, Doxorubicin and ELP-Doxorubicin conjugate on BMG-1 cell lines.](/cms/asset/122c636f-2737-4c47-983b-f5a7c521fc01/idrd_a_853210_f0007_b.jpg)
Figure 8. Confocal fluorescence images showing intracellular localization of free drug, Doxorubicin and ELP-Doxorubicin conjugate.
![Figure 8. Confocal fluorescence images showing intracellular localization of free drug, Doxorubicin and ELP-Doxorubicin conjugate.](/cms/asset/a390599c-e628-48aa-b6af-ccc669b17f18/idrd_a_853210_f0008_c.jpg)